Thus, SS patients, particularly in early stages of SSC, show higher levels of sICOS in serum and increased ICOSL expression in lesional skin, where ICOS costimulation induces the expression of IFNγ and IL-17A as well as profibrogenic cytokines (IL-4) from CD4+ T cells [149]. The gene discussed is CD4; the disease is synovial sarcoma.